Literature DB >> 6417267

99Mo metabolism in sheep after the intravenous injection of [99Mo] thiomolybdates.

J Mason, M Lamand, M J Hynes.   

Abstract

[99Mo]di-, tri-, and tetrathiomolybdate (5.4 to 62.5 mg of Mo) were given by intravenous injection to sheep maintained on a sulfur-supplemented (3 g of S/kg) diet. All the compounds were metabolized very rapidly over the first 15 min postinjection, but relatively slowly thereafter, with a t1/2 of about 30 hr for dithiomolybdate and 40 h for tri- and tetrathiomolybdate. The [99Mo] metabolites present in plasma were identified by Sephadex G-25 chromatography. The main fate of the compounds injected appeared to be stepwise transformation to molybdate and subsequent rapid urinary elimination. Over 90-100 hr more than 90% of the radioactivity was excreted in urine, compared to less than 5% in the feces. The trichloroacetic acid (TCA) solubility of plasma copper and the diamine oxidase activity of ceruloplasmin was depressed, particularly over the first 15 min postinjection and a more persistant TCA-insoluble Cu fraction was apparent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417267     DOI: 10.1016/0162-0134(83)85021-1

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  Hao Wei; Wei-Jian Zhang; Timothy S McMillen; Renee C Leboeuf; Balz Frei
Journal:  Atherosclerosis       Date:  2012-06-16       Impact factor: 5.162

2.  Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo.

Authors:  Hao Wei; Balz Frei; Joseph S Beckman; Wei-Jian Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.